Pre-eclampsia-associated alterations in Wharton's jelly proteoglycans

Area of Science:

• Biochemistry
• Developmental Biology
• Obstetrics

Background:

• Wharton's jelly proteoglycans, primarily decorin, biglycan, and versican, are crucial for umbilical cord structure.
• Alterations in proteoglycan composition can impact tissue mechanical properties and fetal well-being.
• Pre-eclampsia is a pregnancy complication associated with significant physiological changes.

Purpose of the Study:

• To compare the proteoglycan composition of Wharton's jelly in newborns from healthy mothers versus those with pre-eclampsia.
• To investigate potential links between proteoglycan changes and the pathophysiology of pre-eclampsia.

Main Methods:

• Analysis of proteoglycan core proteins and glycosaminoglycan content in Wharton's jelly samples.
• Quantification of proteoglycan molecular masses and ratios.
• Comparison between tissue from pre-eclamptic and normal pregnancies.

Main Results:

• Pre-eclamptic Wharton's jelly exhibits a higher sulphated glycosaminoglycan/protein ratio.
• A lower abundance of all proteoglycan core proteins, particularly higher molecular mass proteins like versican, was observed in pre-eclampsia.
• The same types of proteoglycan core proteins were present in both normal and pre-eclamptic tissues.

Conclusions:

• Pre-eclampsia significantly alters the proteoglycan composition of Wharton's jelly.
• These alterations may compromise the mechanical integrity of the umbilical cord.
• Changes in Wharton's jelly proteoglycans could potentially disrupt fetal circulation in pre-eclamptic pregnancies.